000 01819 a2200517 4500
005 20250515092619.0
264 0 _c20071210
008 200712s 0 0 eng d
022 _a0040-6376
024 7 _a10.1136/thx.2007.087619
_2doi
040 _aNLM
_beng
_cNLM
245 0 0 _aBTS statement on malignant mesothelioma in the UK, 2007.
_h[electronic resource]
260 _bThorax
_cNov 2007
300 _aii1-ii19 p.
_bdigital
500 _aPublication Type: Consensus Development Conference; Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAsbestos
_xtoxicity
650 0 4 _aBiomarkers
_xblood
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aCommunication
650 0 4 _aDiagnosis, Differential
650 0 4 _aDiagnostic Imaging
_xmethods
650 0 4 _aDisability Evaluation
650 0 4 _aDyspnea
_xprevention & control
650 0 4 _aHealth Services Accessibility
_xorganization & administration
650 0 4 _aHumans
650 0 4 _aMesothelioma
_xdiagnosis
650 0 4 _aNurse Clinicians
_xstatistics & numerical data
650 0 4 _aNurse's Role
650 0 4 _aOccupational Diseases
_xdiagnosis
650 0 4 _aPain
_xprevention & control
650 0 4 _aPalliative Care
_xmethods
650 0 4 _aPatient Education as Topic
650 0 4 _aPatient-Centered Care
650 0 4 _aPensions
650 0 4 _aPeritoneal Neoplasms
_xdiagnosis
650 0 4 _aPhysical Examination
650 0 4 _aPleural Effusion
_xtherapy
650 0 4 _aPleural Neoplasms
_xdiagnosis
650 0 4 _aPrognosis
650 0 4 _aSocial Support
650 0 4 _aSurvival Analysis
650 0 4 _aWorkers' Compensation
_xeconomics
773 0 _tThorax
_gvol. 62 Suppl 2
_gp. ii1-ii19
856 4 0 _uhttps://doi.org/10.1136/thx.2007.087619
_zAvailable from publisher's website
999 _c17484091
_d17484091